Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/8980
Title
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Author(s)
Kissling, Esther | Rose, Angela | Emborg, Hanne-Dorthe | Gherasim, Alin Manuel ISCIII | Pebody, Richard | Pozo Sanchez, Francisco ISCIII | Trebbien, Ramona | Mazagatos, Clara ISCIII | Whitaker, Heather | Valenciano, Marta | European IVE group | Larrauri, Amparo ISCIII | Casas Flecha, Inmaculada ISCIII | Delgado-Sanz, Concepcion ISCIII | Oliva Dominguez, Jesus Angel ISCIII
Date issued
2019
Citation
Euro Surveill. 2019 Feb;24(8):1900121.
Language
Inglés
Abstract
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
Subject
Europe | Influenza | Multicentre study | Test-negative design | Vaccination | Vaccine effectiveness | Vaccines and immunisation
Online version
DOI
Collections
Files in this item
This item is licensed under a: Atribución 4.0 Internacional